The effects of hypoxia on the modulation of human TREK-1 potassium channels

被引:24
|
作者
Caley, AJ [1 ]
Gruss, M [1 ]
Franks, NP [1 ]
机构
[1] Blackett Lab, Biophys Sect, Imperial Coll, London SW7 2ZA, England
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2005年 / 562卷 / 01期
关键词
D O I
10.1113/jphysiol.2004.076240
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Two-pore-domain potassium channels are a family of ion channels that are widely believed to play an important role in maintaining and regulating neuronal excitability It has been shown that they can be modulated by an extraordinarily diverse range of endogenous and exogenous factors. One particular member of the family, TREK-1 (also known as KCNK2), is activated by increasing temperature, membrane stretch and internal acidosis, but is also sensitive to the presence of certain polyunsaturated fatty acids (such as arachidonic acid), neuroprotectants (such as riluzole) and volatile and gaseous general anaesthetics (such as halothane and nitrous oxide). It has recently been reported that TREK-1 channels are also affected by oxygen concentrations, and that at the levels of hypoxia that occur in the normal human brain, the channels greatly change their properties and, for example, lose their ability to be modulated by arachidonic acid and internal acidosis. These reports seriously challenge the idea that TREK-1 is a target for general anaesthetics and neuroprotectants. However, in this report we show that TREK-1 is not oxygen sensitive, and its ability to be activated by anaesthetics, arachidonic acid and internal acidosis remains unaltered under conditions of hypoxia. We further show that the protocol used by previous workers to prepare hypoxic solutions of arachidonic acid results in the removal of the compound from solution.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 50 条
  • [1] Structures of the human two-pore domain potassium channels TREK-1 and TREK-2
    Pike, A.
    Dong, Y.
    Mackenzie, A.
    McClenaghan, C.
    Mukhopadhyay, S.
    Burgess-Brown, N.
    Tucker, S.
    Carpenter, E.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C1489 - C1489
  • [2] Inhibition of human TREK-1 channels by bupivacaine
    Punke, MA
    Licher, T
    Pongs, O
    Friederich, P
    ANESTHESIA AND ANALGESIA, 2003, 96 (06): : 1665 - 1673
  • [3] Inhibition of human TREK-1 channels by caffeine and theophylline
    Harinath, S
    Sikdar, SK
    EPILEPSY RESEARCH, 2005, 64 (03) : 127 - 135
  • [4] Activation of TREK-1 background potassium channels by caffeic acid derivatives
    Danthi, SJ
    Enyeart, JA
    Enyeart, JJ
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 428A - 429A
  • [5] Epithelial TREK-1 Potassium Channels Protect Alveolar Barrier Function
    Schwingshackl, A.
    Lopez, B.
    Teng, B.
    Waters, C. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Characterization of Human Myometrial TREK-1 Potassium Channel Currents
    Heyman, Nathanael
    Barnett, Scott
    Buxton, Iain L. O.
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 196A - 196A
  • [7] The potassium current carried by TREK-1 channels in rat cardiac ventricular muscle
    Bodnar, Mandy
    Schlichthoerl, Guenter
    Daut, Juergen
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2015, 467 (05): : 1069 - 1079
  • [8] Pharmacological modulation of TREK-1 channel
    Otalvaro, Edward Francisco Mendez
    Kopec, Wojciech
    de Groot, Bert L.
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 257A - 257A
  • [9] Structural Composition and Signaling Pathways of Alveolar Epithelial TREK-1 Potassium Channels
    Schwingshackl, A.
    Lopez, B.
    Waters, C. M.
    Wei, A.
    Olcese, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [10] TREK-1 Potassium Channels Protect Against Influenza-A-induced ARDS
    Majumder, N.
    Lopez, B.
    Zyrianova, T.
    Ye, A.
    Soohoo, J.
    Kang, H.
    Schwingshackl, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209